The Fort Worth Press - neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer

USD -
AED 3.6725
AFN 64.498045
ALL 82.224051
AMD 357.911109
ANG 1.790403
AOA 917.999992
ARS 1552.245042
AUD 1.487498
AWG 1.8
AZN 1.701568
BAM 1.778889
BBD 2.013452
BDT 124.862431
BGN 1.77347
BHD 0.377187
BIF 3006.125762
BMD 1
BND 1.288366
BOB 11.661285
BRL 5.778103
BSD 0.999695
BTN 93.389482
BWP 13.993424
BYN 3.000114
BYR 19600
BZD 2.010633
CAD 1.430865
CDF 2294.000592
CHF 0.840555
CLF 0.025261
CLP 994.190035
CNY 6.66615
CNH 6.66805
COP 3309.02
CRC 445.311541
CUC 1
CUP 23.992906
CVE 100.292423
CZK 22.169932
DJF 178.024567
DKK 6.80141
DOP 60.539085
DZD 137.094024
EGP 53.720858
ERN 15
ETB 164.079674
EUR 0.90995
FJD 2.297898
FKP 0.756582
GBP 0.757725
GEL 2.590255
GGP 0.756582
GHS 11.730947
GIP 0.756582
GMD 74.000173
GNF 8857.115571
GTQ 7.640288
GYD 209.05242
HKD 7.845155
HNL 26.876953
HRK 6.831965
HTG 130.972791
HUF 333.799019
IDR 18254
ILS 3.254645
IMP 0.756582
INR 93.45245
IQD 1515.562185
IRR 1929053.503608
ISK 124.48026
JEP 0.756582
JMD 158.860526
JOD 0.709026
JPY 159.414008
KES 129.990105
KGS 87.449026
KHR 4078.347196
KMF 448.000085
KPW 900.00035
KRW 1329.397181
KWD 0.31169
KYD 0.833136
KZT 443.84516
LAK 22515.803356
LBP 89525.524706
LKR 332.648142
LRD 167.946083
LSL 16.912988
LTL 2.95274
LVL 0.60489
LYD 6.460474
MAD 9.977716
MDL 18.305023
MGA 4547.687046
MKD 56.015616
MMK 2099.387164
MNT 3606.75335
MOP 8.079605
MRU 40.508252
MUR 47.860043
MVR 15.433829
MWK 1733.487348
MXN 18.45096
MYR 4.098963
MZN 63.907732
NAD 16.912757
NGN 1350.869856
NIO 36.790956
NOK 9.637045
NPR 149.424033
NZD 1.82065
OMR 0.384524
PAB 0.999682
PEN 3.414253
PGK 4.497642
PHP 63.574997
PKR 276.397058
PLN 4.00875
PYG 6228.540504
QAR 3.644326
RON 4.867103
RSD 107.038986
RUB 82.204134
RWF 1479.544504
SAR 3.760904
SBD 8.137041
SCR 13.8922
SDG 601.498572
SEK 10.13571
SGD 1.289235
SHP 0.757117
SLE 22.801691
SLL 20969.503664
SOS 571.283045
SRD 37.437963
STD 20697.981008
STN 22.283565
SVC 8.747021
SYP 13002.000337
SZL 16.91126
THB 33.8665
TJS 9.212201
TMT 3.5
TND 3.02519
TOP 2.40776
TRY 50.441697
TTD 6.768777
TWD 32.958011
TZS 2650.003017
UAH 45.318338
UGX 4148.305798
UYU 40.61103
UZS 12014.188913
VES 915.501901
VND 25687
VUV 121.064676
WST 2.823281
XAF 596.887869
XAG 0.021752
XAU 0.0002631714
XCD 2.70255
XCG 1.801703
XDR 0.707052
XOF 596.887869
XPF 108.472418
YER 236.550078
ZAR 16.95717
ZMK 9001.196037
ZMW 20.479237
ZWL 321.999592
SSP 5928.707524
MXV 2.06991
  • RIO

    -0.3300

    97.04

    -0.34%

  • CMSC

    -0.0400

    20.67

    -0.19%

  • RELX

    0.0000

    33.41

    0%

  • RBGPF

    0.0000

    67.95

    0%

  • BCE

    -0.0700

    21.99

    -0.32%

  • BCC

    -0.0300

    75.66

    -0.04%

  • GSK

    0.8600

    51.08

    +1.68%

  • JRI

    -0.0300

    11.52

    -0.26%

  • NGG

    -0.1200

    76.68

    -0.16%

  • CMSD

    0.0900

    20.54

    +0.44%

  • BTI

    -0.0800

    55.75

    -0.14%

  • AZN

    2.0200

    168.1

    +1.2%

  • BP

    -1.4200

    43.16

    -3.29%

  • RYCEF

    0.4600

    19.7

    +2.34%

  • VOD

    0.0700

    17.02

    +0.41%

neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer

neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer

neurocare group AG, a best practice platform for mental health and performance, is pleased to announce the appointment of Kevin Reeder as Chief Financial Officer of the company, from January 1st 2025.

Text size:

neurocare group AG ("neurocare" or the "Company"), a best practice platform for mental health and performance, is pleased to announce the appointment of Kevin Reeder as Chief Financial Officer of the company, from January 1st 2025.

neurocare appoints Kevin Reeder as CFO starting January 2025

Kevin Reeder holds an MBA from Oxford University and is currently the CEO of the venture capital firm bm|t, one of neurocare´s largest investors. Kevin has a long history in international investment management both in the US and in Europe, spanning venture capital, private equity, and publicly traded investments.

Prior to joining bm|t, Kevin held key roles at INVESCO, Silvergate Capital, GVO Asset Management, and Bank am Bellevue. He also gained experience outside of the investment sector as Head of Data and Credit at M-KOPA, a high-growth company in Africa, where he led fundraising efforts, managed financial operations, and established the company's data analytics platform.

Kevin joined the neurocare board at the end of 2021 and played a key role in fundraising, strategy, and M&A. He will step aside from the board to fully focus on his responsibilities as CFO, driving financial strategy and supporting neurocare's growth initiatives.

"We are delighted to welcome Kevin Reeder as neurocare's new CFO. Having worked with Kevin since joining the board, I have developed a deep respect and admiration for him as a business leader who understands our business and vision. Kevin's exceptional expertise and longstanding familiarity with neurocare's goals make him an ideal fit to help drive our growth and deliver value to our stakeholders," said Tristan de Boysson, Chairman of the Supervisory Board.

"Kevin's appointment as CFO completes neurocare's Global Leadership Team at a time of such exciting growth for our innovative company," said Thomas Mechtersheimer, Founder & CEO of neurocare. "Having worked closely with Kevin as a Board member, I am confident that his deep understanding of our business will enable us to drive neurocare's growth faster right away. On a personal note, I am much looking forward to sharing my life's professional vision and purpose with someone so energetic and equally purpose driven."

"I am honored to step into the role of CFO at neurocare and to be part of such a forward-thinking company dedicated to transforming mental health and performance," said Kevin Reeder. "Having had the privilege of working with neurocare as a Board member, I have a deep appreciation for the team's vision and the positive impact we're making. I look forward to leveraging my experience to support neurocare's growth and financial strategy as we continue to expand our reach and become a global leader in mental healthcare."

Contact Information:

Sally Remington
Global Marketing Manager
[email protected]
+49 152 2305 8385

SOURCE: neurocare group AG

W.Matthews--TFWP